期刊名称：Psychologie & NeuroPsychiatrie du vieillissement
印刷版ISSN：1760-1703
电子版ISSN：1950-6988
出版年度：2005
卷号：3
期号：1
页码：51-55
出版社：John Libbey Eurotext
摘要：Medical treatment of severe dementia is now available. Decrease of psychobehavioral disturbances, autonomy loss or care-giver burden appear as the main objective rather than reduction of cognitive deficits. Acetylcholinesterase inhibitors (AChE-I) should be maintained in patients with severe dementia when initiated in mild or moderate dementia. Memantine is the specific treatment for patients with severe dementia, even if they received AChE-I. To treat the psychobehavioral disturbancies, serotoninergic agents and thymoregulators are the first line drugs. Medical treatment should only be co-prescribed with a global care of all co-morbidities, autonomy loss and patient’s and care-giver’s burden, and associated with psychological and organisational support.
关键词：severe dementia; medical treatment; acetylcholinesterase inhibitor; memantine
Loading...
